Umbilical cord blood mesenchymal stem cell in the treatment of chronic obstructive pulmonary disease progress of study

Chronic obstructive pulmonary disease (COPD) which in the current world fourth to the cause of death,is a chronic airway inflammation and gradual destruction of lung parenchyma as feature,most of the situation is due to smoking causes[1],mainly by destroying terminal bronchial and alveolar walls,to increase ventilation.Patients usually died of emphysema semeiologically treats (including:oxygen cure,anti-infection,reduce phlegm,smooth wheezing,diastolic spasm of bronchial etc) invalid and gradually appear of respiratory failure [2].People are constantly looking for treatment method of COPD,in addition to early intervention and semeiologically support in the disposal,lung transplant to become a major radical method.But along with the development of science and technology,stem cell therapy by the mass of the attention,the umbilical cord blood mesenchymal stem cells (MSCs) treatment of COPD UCB-particularly outstanding.This article reviewed the relevant research progress are as follows. Key words: Stem cell; Mesenchymal stem cell; Chronic obstructive pulmonary disease